Tumor cell recognition by γδ T lymphocytes: T-cell receptor vs. NK-cell receptors

OncoImmunology

Volumn 2, Issue 1, 2013, Pages

  Correia, Daniel V ^a   Lopes, António ^a,b   Silva Santos, Bruno ^a,c  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b MRC UNIVERSITY OF GLASGOW CENTRE FOR VIRUS RESEARCH   (United Kingdom)

^c INSTITUTO GULBENKIAN DE CIÊNCIA   (Portugal)

Author keywords

T cell; NK cell; NK receptor; NKG2D; T cell receptor

Indexed keywords

GAMMA INTERFERON; ISOPENTHENYL PYROPHOSPHATE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 2; NATURAL CYTOTOXICITY TRIGGERING RECEPTOR 3; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2D; PYROPHOSPHATE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG;

ANTIGEN FUNCTION; ANTIGEN PRESENTATION; ARTICLE; CELL AGGREGATION; GAMMA DELTA T LYMPHOCYTE; HUMAN; IMMUNOSTIMULATION; LIGAND BINDING; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE SUBPOPULATION; MOLECULAR RECOGNITION; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY;

EID: 84879076933     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.22892     Document Type: Article

References (36)

1. Hayday AC. Gammadelta T cells and the lymphoid stress-surveillance response. Immunity 2009; 31:184-96; PMID:19699170; http://dx.doi.org/10.1016/j. immuni.2009.08.006.
2. Gomes AQ, Correia DV, Silva-Santos B. Non-classical major histocompatibility complex proteins as determinants of tumour immunosurveillance. EMBO Rep 2007; 8:1024-30; http://dx.doi.org/10.1038/sj.embor.7401090; PMID:17972902.
3. Lanier LL. Up on the tightrope: natural killer cell activation and inhibition. Nat Immunol 2008; 9:495-502; http://dx.doi.org/10.1038/ni1581; PMID:18425106.
4. Pont F, Familiades J, Déjean S, Fruchon S, Cendron D, Poupot M, et al. The gene expression profile of phosphoantigen-specific human γδ T lymphocytes is a blend of αβ T-cell and NK-cell signatures. Eur J Immunol 2012; 42:228-40; http://dx.doi. org/10.1002/eji.201141870; PMID:21968650.
5. Nedellec S, Bonneville M, Scotet E. Human Vgamma9Vdelta2 T cells: from signals to functions. Semin Immunol 2010; 22:199-206; PMID:20447835; http://dx.doi.org/10.1016/j.smim.2010.04.004.
6. Toutirais O, Cabillic F, Le Friec G, Salot S, Loyer P, Le Gallo M, et al. DNAX accessory molecule-1 (CD226) promotes human hepatocellular carcinoma cell lysis by Vgamma9Vdelta2 T cells. Eur J Immunol 2009; 39:1361-8; http://dx.doi.org/10.1002/eji.200838409; PMID:19404979.
7. Correia DV, Fogli M, Hudspeth K, da Silva MG, Mavilio D, Silva-Santos B. Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells. Blood 2011; 118:992-1001; http://dx.doi.org/10.1182/blood-2011-02-339135; PMID:21633088.
8. Carena I, Shamshiev A, Donda A, Colonna M, Libero GD. Major histocompatibility complex class I molecules modulate activation threshold and early signaling of T cell antigen receptor-gamma/delta stimulated by nonpeptidic ligands. J Exp Med 1997; 186:1769-74; PMID:9362537; http://dx.doi. org/10.1084/jem.186.10.1769.
9. Fisch P, Malkovsky M, Braakman E, Sturm E, Bolhuis RL, Prieve A, et al. Gamma/delta T cell clones and natural killer cell clones mediate distinct patterns of non-major histocompatibility complexrestricted cytolysis. J Exp Med 1990; 171:1567-79; PMID:2185329; http://dx.doi.org/10.1084/jem.171.5.1567.
10. Morita CT, Jin C, Sarikonda G, Wang H. Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev 2007; 215:59-76; PMID:17291279; http://dx.doi. org/10.1111/j.1600-065X.2006.00479.x.
11. Gomes AQ, Martins DS, Silva-Santos B. Targeting γδ T lymphocytes for cancer immunotherapy: from novel mechanistic insight to clinical application. Cancer Res 2010; 70:10024-7; http://dx.doi.org/10.1158/0008-5472.CAN-10-3236; PMID:21159627.
12. Hannani D, Ma Y, Yamazaki T, Déchanet-Merville J, Kroemer G, Zitvogel L. Harnessing γδ T cells in anticancer immunotherapy. Trends Immunol 2012; 33:199-206; http://dx.doi.org/10.1016/j. it.2012.01.006; PMID:22364810.
13. Gomes AQ, Correia DV, Grosso AR, Lança T, Ferreira C, Lacerda JF, et al. Identification of a panel of ten cell surface protein antigens associated with immunotargeting of leukemias and lymphomas by peripheral blood gammadelta T cells. Haematologica 2010; 95:1397-404; http://dx.doi.org/10.3324/haematol. 2009.020602; PMID:20220060.
14. Bonneville M, O'Brien RL, Born WK. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol 2010; 10:467-78; http://dx.doi.org/10.1038/nri2781; PMID:20539306.
15. Wrobel P, Shojaei H, Schittek B, Gieseler F, Wollenberg B, Kalthoff H, et al. Lysis of a broad range of epithelial tumour cells by human gamma delta T cells: involvement of NKG2D ligands and T-cell receptor- versus NKG2D-dependent recognition. Scand J Immunol 2007; 66:320-8; PMID:17635809; http://dx.doi.org/10.1111/j.1365-3083.2007.01963.x.
16. Gober HJ, Kistowska M, Angman L, Jenö P, Mori L, De Libero G. Human T cell receptor gammadelta cells recognize endogenous mevalonate metabolites in tumor cells. J Exp Med 2003; 197:163-8; PMID:12538656; http://dx.doi.org/10.1084/jem.20021500.
17. Bukowski JF, Morita CT, Tanaka Y, Bloom BR, Brenner MB, Band H. V gamma 2V delta 2 TCRdependent recognition of non-peptide antigens and Daudi cells analyzed by TCR gene transfer. J Immunol 1995; 154:998-1006; PMID:7529807.
18. Scotet E, Martinez LO, Grant E, Barbaras R, Jenö P, Guiraud M, et al. Tumor recognition following Vgamma9Vdelta2 T cell receptor interactions with a surface F1-ATPase-related structure and apolipoprotein A-I. Immunity 2005; 22:71-80; PMID:15664160; http://dx.doi.org/10.1016/j. immuni.2004.11.012.
19. Mookerjee-Basu J, Vantourout P, Martinez LO, Perret B, Collet X, Périgaud C, et al. F1-adenosine triphosphatase displays properties characteristic of an antigen presentation molecule for Vgamma9Vdelta2 T cells. J Immunol 2010; 184:6920-8; http://dx.doi. org/10.4049/jimmunol.0904024; PMID:20483757.
20. Harly C, Guillaume Y, Nedellec S, Peigné CM, Mönkkönen H, Mönkkönen J, et al. Key implication of CD277/butyrophilin-3 (BTN3A) in cellular stress sensing by a major human γδ T-cell subset. Blood 2012; 120:2269-79; http://dx.doi.org/10.1182/blood-2012-05-430470; PMID:22767497.
21. Willcox CR, Pitard V, Netzer S, Couzi L, Salim M, Silberzahn T, et al. Cytomegalovirus and tumor stress surveillance by binding of a human γδ T cell antigen receptor to endothelial protein C receptor. Nat Immunol 2012; 13:872-9; http://dx.doi. org/10.1038/ni.2394; PMID:22885985.
22. Xu B, Pizarro JC, Holmes MA, McBeth C, Groh V, Spies T, et al. Crystal structure of a gammadelta T-cell receptor specific for the human MHC class I homolog MICA. Proc Natl Acad Sci U S A 2011; 108:2414-9; http://dx.doi.org/10.1073/pnas.1015433108; PMID:21262824.
23. Lança T, Correia DV, Moita CF, Raquel H, Neves-Costa A, Ferreira C, et al. The MHC class Ib protein ULBP1 is a nonredundant determinant of leukemia/lymphoma susceptibility to gammadelta T-cell cytotoxicity. Blood 2010; 115:2407-11; http://dx.doi.org/10.1182/blood-2009-08-237123; PMID:20101024.
24. Raulet DH, Guerra N. Oncogenic stress sensed by the immune system: role of natural killer cell receptors. Nat Rev Immunol 2009; 9:568-80; http://dx.doi. org/10.1038/nri2604; PMID:19629084.
25. Das H, Groh V, Kuijl C, Sugita M, Morita CT, Spies T, et al. MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigendependent effector function. Immunity 2001; 15:83-93; PMID:11485740; http://dx.doi.org/10.1016/S1074-7613(01)00168-6.
26. Bauer S, Groh V, Wu J, Steinle A, Phillips JH, Lanier LL, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science 1999; 285:727-9; PMID:10426993; http://dx.doi.org/10.1126/science.285.5428.727.
27. Strid J, Roberts SJ, Filler RB, Lewis JM, Kwong BY, Schpero W, et al. Acute upregulation of an NKG2D ligand promotes rapid reorganization of a local immune compartment with pleiotropic effects on carcinogenesis. Nat Immunol 2008; 9:146-54; PMID:18176566; http://dx.doi.org/10.1038/ni1556.
28. Girardi M, Oppenheim DE, Steele CR, Lewis JM, Glusac E, Filler R, et al. Regulation of cutaneous malignancy by gammadelta T cells. Science 2001; 294:605-9; PMID:11567106; http://dx.doi. org/10.1126/science.1063916.
29. Guerra N, Tan YX, Joncker NT, Choy A, Gallardo F, Xiong N, et al. NKG2D-deficient mice are defective in tumor surveillance in models of spontaneous malignancy. Immunity 2008; 28(5):571-80; PMID:18394936; http://dx.doi.org/10.1016/j. immuni.2008.02.016.
30. Oppenheim DE, Roberts SJ, Clarke SL, Filler R, Lewis JM, Tigelaar RE, et al. Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol 2005; 6:928-37; PMID:16116470; http://dx.doi. org/10.1038/ni1239.
31. Rincon-Orozco B, Kunzmann V, Wrobel P, Kabelitz D, Steinle A, Herrmann T. Activation of V gamma 9V delta 2 T cells by NKG2D. J Immunol 2005; 175:2144-51; PMID:16081780.
32. Nedellec S, Sabourin C, Bonneville M, Scotet E. NKG2D costimulates human V gamma 9V delta 2 T cell antitumor cytotoxicity through protein kinase C theta-dependent modulation of early TCRinduced calcium and transduction signals. J Immunol 2010; 185:55-63; http://dx.doi.org/10.4049/jimmunol. 1000373; PMID:20511557.
33. Carbone E, Neri P, Mesuraca M, Fulciniti MT, Otsuki T, Pende D, et al. HLA class I, NKG2D, and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells. Blood 2005; 105:251-8; http://dx.doi.org/10.1182/blood-2004-04-1422; PMID:15328155.
34. Lakshmikanth T, Burke S, Ali TH, Kimpfler S, Ursini F, Ruggeri L, et al. NCRs and DNAM-1 mediate NK cell recognition and lysis of human and mouse melanoma cell lines in vitro and in vivo. J Clin Invest 2009; 119:1251-63; http://dx.doi. org/10.1172/JCI36022; PMID:19349689.
35. Thedrez A, Sabourin C, Gertner J, Devilder MC, Allain-Maillet S, Fournié JJ, et al. Self/non-self discrimination by human gammadelta T cells: simple solutions for a complex issue? Immunol Rev 2007; 215:123-35; PMID:17291284; http://dx.doi. org/10.1111/j.1600-065X.2006.00468.x.
36. Halary F, Peyrat MA, Champagne E, Lopez-Botet M, Moretta A, Moretta L, et al. Control of self-reactive cytotoxic T lymphocytes expressing gamma delta T cell receptors by natural killer inhibitory receptors. Eur J Immunol 1997; 27:2812-21; http://dx.doi. org/10.1002/eji.1830271111; PMID:9394804.